WorldPingCapricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STAT
WorldPing“Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has Duchenne muscular dystrophy.
Brief by WorldPing · Original reporting by STAT
WorldPingBetween success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for developing cancer therapies.
Brief by WorldPing · Original reporting by STAT
Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimer’s, Parkinson’s, Huntington’s disease, and motor neurone disease.
Brief by WorldPing · Original reporting by ScienceDaily
WorldPing